News and Announcements
Browse the articles below to learn more about our faculty’s latest achievements, awards and honors.
Two Northwestern Medicine studies are improving the understanding of epigenetic mechanisms in cancer development and progression, and identifying novel cancer driver genes that may help identify patients who will benefit from immunotherapy.
- 02.17.2021Higher levels of a certain type of immune cell may explain why immunotherapy for prostate cancer is more effective in Black men than in white men, researchers say.
- 02.16.2021Ashley Ross is joined by Daniel Spratt presenting a European Association of Urology publication on A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer.
- 02.10.2021Discovery paves way to precision medicine for prostate cancer in all races.
- 01.26.2021The Moore family and Dr. Shilajit Kundu from Northwestern Medicine tell their remarkable story of survival and check in with baby Julia one year after coming face-to-face with near tragedy.
- 01.26.2021Northwestern Medicine’s Dr. Shilajit Kundu helps a couple navigate testicular cancer and family planning.
Featuring: Ashley Ross, MD, PhD, urologic oncology at Northwestern Memorial Hospital.
Northwestern Medicine investigators have discovered that oncogenes contain specific epigenetic markers called broad genic repression domains, which could help identify potential therapeutic targets for cancer treatment.
Qi Cao, PhD, study discovered that oncogenes contain specific epigenetic markers called broad genic repression domains (BGRDs), according to findings published in Nature Communications.
During the second prostate cancer session at the 2020 Annual Meeting of the Society of Urologic Oncology (SUO), Drs. Neal Shore and Ashley Evan Ross debated the use of relugolix as a new standard of care for androgen deprivation therapy (ADT) for the treatment of prostate cancer.
- Navigating My Career: Lessons Learned and Best Practices from an Early-Career Urologist with Dr. Emilie Johnson12.10.2020
Emilie Johnson, MD, MPH, presents her talk called, "Navigating My Career: Lessons Learned and Best Practices from an Early-Career Urologist." This was the keynote lecture from the 2020 virtual AUA Career & Resources Fair.
Vishal Kothari, PhD, and Ashley Ross, MD, PhD, have been named George M. Eisenberg Foundation Scholars by the Northwestern University Clinical and Translational Sciences (NUCATS) Institute.
- Study by Dr. Stephanie Kielb Suggests Restricted Interview Questions Persist in Urology Match Process11.27.2020
In this video, Stephanie J. Kielb, MD, discusses the recent Urology Practice study, “The impact of stricter guidelines on post-interview contact, restricted interview topics and differences by gender in the urology match.”
Yara Rodriguez, a PhD candidate and member of the Abdulkadir Lab, was awarded the highly competitive American Association of University Women (AAUW) International Fellowship.
In this video, Sarki Abdulkadir, MD, PhD, discusses the challenges of targeting MYC in prostate cancer.
Edward Schaeffer, MD, PhD, presented on "Prostate Cancer Genetics: Heritable Causes that Impact Treatment" at the 2020 Prostate Cancer Academy.
Maxwell Edmonds, a third-year medical student in the Medical Scientist Training Program (MSTP), recently defended his doctoral thesis on generating testicular organoids and looks back on his Feinberg journey so far.
A new study found that Black men with metastatic prostate cancer were more likely to have tumor mutations than white or Asian men, highlighting the significance genetic drivers have in increasing one's risk for developing aggressive prostate cancer.
Black men with metastatic prostate cancer were more likely to have tumor mutations than white or Asian men, according to a study by Edward Schaeffer, MD, PhD. Published in The New England Journal of Medicine, the study highlights the significance genetic drivers have in increasing one’s risk for developing aggressive prostate cancer.
Sarki Abdulkadir, MD, PhD, was named on the Illinois Science & Technology Coalition’s third annual list of “Researchers to Know” at Illinois universities under the category “Preventing Disease.”
- Dr. Edward Schaeffer joins WGN news to talk about National Prostate Cancer Awareness Month, and what patients need to know about screening, treatments, and advances in prostate cancer09.20.2020
Dr. Edward Schaeffer joins WGN news to talk about National Prostate Cancer Awareness Month, and what patients need to know about screening, treatments, and advances in prostate cancer
Inhibiting an epigenetic regulator called DOT1L could be a key to slowing treatment-resistant prostate cancer, according to a recent Northwestern Medicine study.
- Survival following upfront chemotherapy for treatment-naïve metastatic prostate cancer: a real-world retrospective cohort study by resident Adam Weiner09.09.2020
Survival following upfront chemotherapy for treatment-naïve metastatic prostate cancer: a real-world retrospective cohort study by resident Adam Weiner
Sarki Abdulkadir, MD, PhD, has been named the winner of the 2020 Tripartite Legacy Faculty Prize in Translational Science and Education for his work investigating the molecular pathways that drive prostate cancer.
- 07.31.2020Dr. Kielb discusses the impact of this simple intervention on patients and residents.
- Dr. Catalona's Virtual AUA Lecture: Controversies in Urology: Prostate Cancer Active Surveillance Can Be Done with mpMRI and Biomarkers; Biopsies are No Longer Necessary06.29.2020
Read a summary of a panel featuring Dr. Catalona at the Virtual 2020 AUA Meeting.
- Dr. Brannigan Participates in AUA Panel Discussion: Multidisciplinary Discussion on Fertility, Hypogonadism, and Sexual Function for Testis Cancer Patients06.28.2020Dr. Brannigan participates in a panel discussion to evaluate fertility, hypogonadism and sexual function among patients with testis cancer.
- AUA 2020 :Dr. Meeks on the Association of Pathologic Response to Neoadjuvant Pembrolizumab with Tumor Subtype from the PURE-01 StudyJune06.27.2020Dr. Meeks discusses how he performed transcriptome RNA-Seq on transurethral resection specimens of 88 patients prior to receiving three cycles of pembrolizumab.
Dr. Bowen paticipates in a multidisciplinary team team that provides transition-related surgeries, fertility counseling, and psychology.